Taysha Gene Therapies, Inc. (TSHA)
4.005
-0.06
(-1.35%)
USD |
NASDAQ |
Nov 17, 16:00
4.005
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Total Assets (Quarterly) : 435.03M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 435.03M |
| June 30, 2026 | 470.43M |
| March 31, 2026 | 300.35M |
| December 31, 2025 | 483.73M |
| September 30, 2025 | 316.55M |
| June 30, 2025 | 333.33M |
| March 31, 2025 | 138.36M |
| December 31, 2024 | 276.41M |
| September 30, 2024 | 180.22M |
| June 30, 2024 | 200.39M |
| March 31, 2024 | 153.00M |
| December 31, 2023 | 266.99M |
| September 30, 2023 | 195.77M |
| Date | Value |
|---|---|
| June 30, 2023 | 81.54M |
| March 31, 2023 | 101.60M |
| December 31, 2022 | 128.63M |
| September 30, 2022 | 111.47M |
| June 30, 2022 | 142.33M |
| March 31, 2022 | 165.98M |
| December 31, 2021 | 213.96M |
| September 30, 2021 | 241.04M |
| June 30, 2021 | 241.86M |
| March 31, 2021 | 242.83M |
| December 31, 2020 | 258.88M |
| September 30, 2020 | 279.27M |
| June 30, 2020 | 11.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Imunon, Inc. | 12.01M |
| Altimmune, Inc. | 495.65M |
| Agenus, Inc. | 245.55M |
| Amgen, Inc. | 96.05B |
| Anika Therapeutics, Inc. | 189.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 78.06M |
| Shareholders Equity (Quarterly) | 356.97M |
| Debt to Equity Ratio | 0.1531 |
| Current Ratio | 18.56 |
| Net Debt Paydown Yield | 0.07% |